EA201791542A1 - Лекарственный препарат, устройство для лечения заболеваний крови, косметическое средство, продукт питания и напиток, использующий вещество, полученное методом синтеза в процессе горения - Google Patents
Лекарственный препарат, устройство для лечения заболеваний крови, косметическое средство, продукт питания и напиток, использующий вещество, полученное методом синтеза в процессе горенияInfo
- Publication number
- EA201791542A1 EA201791542A1 EA201791542A EA201791542A EA201791542A1 EA 201791542 A1 EA201791542 A1 EA 201791542A1 EA 201791542 A EA201791542 A EA 201791542A EA 201791542 A EA201791542 A EA 201791542A EA 201791542 A1 EA201791542 A1 EA 201791542A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- synthesis method
- blood
- drinks
- drugs
- treatment
- Prior art date
Links
- 239000002537 cosmetic Substances 0.000 title abstract 3
- 235000013305 food Nutrition 0.000 title abstract 2
- 208000014951 hematologic disease Diseases 0.000 title abstract 2
- 239000000126 substance Substances 0.000 title abstract 2
- 238000001308 synthesis method Methods 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000919 ceramic Substances 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 239000008280 blood Substances 0.000 abstract 2
- 210000004369 blood Anatomy 0.000 abstract 2
- 230000017531 blood circulation Effects 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 abstract 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 230000004087 circulation Effects 0.000 abstract 1
- 238000002485 combustion reaction Methods 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000002071 nanotube Substances 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 229910052710 silicon Inorganic materials 0.000 abstract 1
- 239000010703 silicon Substances 0.000 abstract 1
- 229910052719 titanium Inorganic materials 0.000 abstract 1
- 239000010936 titanium Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/22—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/242—Gold; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/44—Elemental carbon, e.g. charcoal, carbon black
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Virology (AREA)
- Neurology (AREA)
- Communicable Diseases (AREA)
- Birds (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Mycology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Addiction (AREA)
- Vascular Medicine (AREA)
Abstract
Раскрыты фармацевтическая композиция, косметический продукт и продукт питания или напиток, каждый из которых включает пористую керамику, полученную по методу синтеза в процессе горения исходного вещества, содержащего (1) титан и (2) по меньшей мере один элемент, выбранный из группы, которая состоит из углерода, азота и кремния; фармацевтическая композиция и косметический продукт, каждый из которых включает жидкость, содержащую радикалы и нанотрубки; и устройство для лечения заболеваний крови, имеющее канал кровотока для экстракорпоральной циркуляции крови пациента, при этом канал кровотока снабжен вышеуказанной пористой керамикой и пористую керамику и кровь вводят в контакт друг с другом.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015001176 | 2015-01-06 | ||
JP2015162792 | 2015-08-20 | ||
PCT/JP2016/050106 WO2016111285A1 (ja) | 2015-01-06 | 2016-01-05 | 燃焼合成材料を利用した医薬組成物、血液処理装置、化粧料及び飲食品 |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201791542A1 true EA201791542A1 (ru) | 2018-03-30 |
Family
ID=56355972
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201791542A EA201791542A1 (ru) | 2015-01-06 | 2016-01-05 | Лекарственный препарат, устройство для лечения заболеваний крови, косметическое средство, продукт питания и напиток, использующий вещество, полученное методом синтеза в процессе горения |
Country Status (9)
Country | Link |
---|---|
US (1) | US10471096B2 (ru) |
EP (1) | EP3243517A4 (ru) |
JP (1) | JP6706827B2 (ru) |
CN (1) | CN107106600A (ru) |
AU (1) | AU2016205715B2 (ru) |
CA (1) | CA2972949A1 (ru) |
EA (1) | EA201791542A1 (ru) |
TW (1) | TWI713485B (ru) |
WO (1) | WO2016111285A1 (ru) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7058470B2 (ja) * | 2017-03-23 | 2022-04-22 | 全星薬品工業株式会社 | 医薬品の製造工程の工程分析方法 |
JP2019104688A (ja) * | 2017-12-08 | 2019-06-27 | 大平 猛 | 治療方法 |
EP3760212A4 (en) * | 2018-02-28 | 2021-12-01 | Clinical Research Of Fecal Microbiota Transplantation Japan Corporation | COMPOSITION WITH LIVING MICRO-ORGANISMS AND MANUFACTURING METHOD FOR THEREFORE |
JP2020184002A (ja) * | 2019-05-07 | 2020-11-12 | キヤノン株式会社 | 光学素子の製造方法、光学素子、撮像装置、および光学機器 |
KR20220003559A (ko) * | 2019-08-26 | 2022-01-10 | 신바이오시스 가부시키가이샤 | 생체 도입 보조제 및 그의 이용 방법 |
CN111747757A (zh) * | 2020-05-31 | 2020-10-09 | 深圳陶陶科技有限公司 | 一种陶瓷材料的制备方法及陶瓷材料 |
CN112010638A (zh) * | 2020-05-31 | 2020-12-01 | 深圳陶陶科技有限公司 | 一种陶瓷材料及其制备方法 |
CA3214543A1 (en) * | 2021-04-09 | 2022-10-13 | Leonard Sonnenschein | Bioavailable mixture providing safe, broad-spectrum, antipathogenic, health, fitness, neurological, and homeostatic benefits |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4909842A (en) * | 1988-10-21 | 1990-03-20 | The United States Of America As Represented By The United States Department Of Energy | Grained composite materials prepared by combustion synthesis under mechanical pressure |
US4988645A (en) * | 1988-12-12 | 1991-01-29 | The United States Of America As Represented By The United States Department Of Energy | Cermet materials prepared by combustion synthesis and metal infiltration |
IL96313A (en) * | 1989-11-14 | 1995-03-30 | Sangi Kk | Antibacterial ceramic |
WO1994017012A1 (en) * | 1993-01-27 | 1994-08-04 | University Of Cincinnati | Porous ceramic and porous ceramic composite structure |
US5217583A (en) * | 1991-01-30 | 1993-06-08 | University Of Cincinnati | Composite electrode for electrochemical processing and method for using the same in an electrolytic process for producing metallic aluminum |
US5316718A (en) * | 1991-06-14 | 1994-05-31 | Moltech Invent S.A. | Composite electrode for electrochemical processing having improved high temperature properties and method for preparation by combustion synthesis |
WO1995014484A1 (fr) | 1993-11-26 | 1995-06-01 | Kimurakogyo Co., Ltd. | GENERATEUR DE RADICAUX LIBRES $i(IN VIVO) |
US5558071A (en) * | 1994-03-07 | 1996-09-24 | Combustion Electromagnetics, Inc. | Ignition system power converter and controller |
JP3021113U (ja) * | 1995-07-28 | 1996-02-16 | ファイルド株式会社 | 健康用テープ |
JPH115729A (ja) * | 1997-06-17 | 1999-01-12 | Shoji Hyodo | 光触媒機能を有する化粧料 |
IL134830A0 (en) * | 2000-03-01 | 2001-05-20 | Chay 13 Medical Res Group N V | Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them |
CA2402733A1 (en) * | 2000-03-14 | 2001-09-20 | Burkhard Goke | Effects of glucagon-like peptide-1 (7-36) on antro-pyloro-duodenal motility |
JP2002316946A (ja) * | 2001-04-19 | 2002-10-31 | Japan Science & Technology Corp | 光触媒の生体内への注入方法ならびに生体内への打ち込み粒子およびその製造方法 |
JP3988030B2 (ja) * | 2001-06-07 | 2007-10-10 | 修 山田 | セラミックス系多孔質材料の製造方法 |
JP2003192467A (ja) * | 2001-12-20 | 2003-07-09 | Tkx:Kk | 開放気孔を有する多孔質材料の製造方法 |
WO2004091308A1 (ja) * | 2003-04-14 | 2004-10-28 | Yasuo Satou | 生物の排泄物衛生化方法 |
JP4051569B2 (ja) * | 2004-03-22 | 2008-02-27 | 修 山田 | 金属間化合物系多孔質材料の製造方法 |
JP2005270358A (ja) * | 2004-03-25 | 2005-10-06 | Mitsuo Shimada | 胆汁酸の除去方法および除去装置ならびに血液浄化剤 |
JP4601361B2 (ja) | 2004-08-31 | 2010-12-22 | 修 山田 | 銀イオン水生成用材料とそれを用いる銀イオン水製造方法 |
GB0603138D0 (en) * | 2006-02-16 | 2006-03-29 | Queen Mary & Westfield College | Virucidal materials |
CN101023752B (zh) * | 2006-02-23 | 2012-06-20 | 山田修 | 银离子水生成用材料及采用此材料的银离子水制造方法 |
US8461129B2 (en) * | 2006-09-25 | 2013-06-11 | Archer Daniels Midland Company | Superabsorbent surface-treated carboxyalkylated polysaccharides and process for producing same |
EP2103312A4 (en) * | 2006-12-12 | 2011-06-01 | Nat Univ Corp Tokyo Med & Dent | PREPARATION FOR STERILIZATION OR DISINFECTION OF TISSUE |
SE531318C2 (sv) * | 2007-02-22 | 2009-02-24 | Tigran Technologies Ab Publ | Injicerbar suspension innefattande titan-,titanlegerings- eller titanoxidpartiklar av mikrostruktur |
US20130084243A1 (en) * | 2010-01-27 | 2013-04-04 | Liliane Goetsch | Igf-1r specific antibodies useful in the detection and diagnosis of cellular proliferative disorders |
JP5102749B2 (ja) | 2008-01-10 | 2012-12-19 | 荒城 慶作 | 口腔洗滌イオン水 |
CN102164579B (zh) * | 2008-09-25 | 2014-10-15 | 赛福伦公司 | 苯达莫司汀的液体配制品 |
US20110028412A1 (en) * | 2009-08-03 | 2011-02-03 | Cappellos, Inc. | Herbal enhanced analgesic formulations |
-
2016
- 2016-01-05 CA CA2972949A patent/CA2972949A1/en not_active Abandoned
- 2016-01-05 AU AU2016205715A patent/AU2016205715B2/en not_active Ceased
- 2016-01-05 EP EP16735024.8A patent/EP3243517A4/en not_active Withdrawn
- 2016-01-05 JP JP2016568722A patent/JP6706827B2/ja active Active
- 2016-01-05 TW TW105100248A patent/TWI713485B/zh active
- 2016-01-05 EA EA201791542A patent/EA201791542A1/ru unknown
- 2016-01-05 US US15/540,830 patent/US10471096B2/en active Active
- 2016-01-05 CN CN201680004177.6A patent/CN107106600A/zh active Pending
- 2016-01-05 WO PCT/JP2016/050106 patent/WO2016111285A1/ja active Application Filing
Also Published As
Publication number | Publication date |
---|---|
JP6706827B2 (ja) | 2020-06-10 |
EP3243517A1 (en) | 2017-11-15 |
JPWO2016111285A1 (ja) | 2017-10-12 |
AU2016205715A1 (en) | 2017-07-20 |
TWI713485B (zh) | 2020-12-21 |
US20180008633A1 (en) | 2018-01-11 |
US10471096B2 (en) | 2019-11-12 |
CA2972949A1 (en) | 2016-07-14 |
AU2016205715B2 (en) | 2020-10-29 |
EP3243517A4 (en) | 2018-08-29 |
CN107106600A (zh) | 2017-08-29 |
TW201630615A (zh) | 2016-09-01 |
WO2016111285A1 (ja) | 2016-07-14 |
EP3243517A8 (en) | 2018-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201791542A1 (ru) | Лекарственный препарат, устройство для лечения заболеваний крови, косметическое средство, продукт питания и напиток, использующий вещество, полученное методом синтеза в процессе горения | |
EA201890725A1 (ru) | Агонисты фарнезоидного х-рецептора и их применение | |
CY1122549T1 (el) | Παραγωγα καρβαζολης | |
BR112019000692A2 (pt) | moduladores de somatostatina e usos destes | |
BR112021019070A2 (pt) | Ligantes de pseudoquinase tyk2 | |
MX2017016134A (es) | Aril dihidro-2h-benzo[b][1,4]oxazina sulfonamida y compuestos relacionados para uso como agonistas de rory y el tratamiento de enfermedad. | |
NO20071240L (no) | Terapeutiske anvendelser av RTP801 inhibitorer | |
EA201891399A1 (ru) | Бипиразолильные производные, пригодные для лечения аутоиммунных заболеваний | |
MX2019004280A (es) | Organonitro-sulfoalquilo y compuestos relacionados y composiciones farmacéuticas para uso en medicina. | |
CY1122818T1 (el) | Παραγωγα 3-((ετερο-)αρυλ)-αλκυλ-8-αμινο-2-οξο-1,3-διαζα- σπε1ρο-[4.5]-δεκανιου | |
BR112021015616A2 (pt) | Ligantes de pseudoquinase tyk2 | |
MX2018002223A (es) | Derivados de insulina novedosos y usos medicos de los mismos. | |
EP4233913A3 (en) | Improved bromocriptine formulations | |
MX2022005563A (es) | Ligandos de la pseudoquinasa tyk2. | |
EA201991951A1 (ru) | Низковязкие высококонцентрированные составы на основе эволокумаба и способы их получения | |
WO2018154118A3 (en) | Aromatic compounds which enhance notch signaling, for use in therapy | |
EA202190281A1 (ru) | Производные 3-((гетеро-)арил)-8-амино-2-оксо-1,3-диаза-спиро[4,5]декана | |
EA201891610A1 (ru) | Производные 3-(карбоксиэтил)-8-амино-2-оксо-1,3-диазаспиро[4.5]декана | |
EA202092156A1 (ru) | Модифицированные олигонуклеотиды и способы применения в лечении таупатий | |
ATE447963T1 (de) | Verwendung von lavendelöl zur prophylaxe und behandlung von somatisierungsstörungen und von posttraumatischer stresserkrankung | |
BR112021014566A2 (pt) | Moduladores de gpr35 | |
MX2017003015A (es) | Metodo para tratar canceres solidos y/o metastasis de los mismos, medicamentos para los mismos, y metodo para predecir el resultado clinico para tratar canceres solidos y/o metastasis de los mismos. | |
MX2018005226A (es) | Formulaciones de anticuerpo anti-factor d. | |
BR112022002390A2 (pt) | Inibidores de jak | |
RU2017100665A (ru) | Внутрикожное введение препарата иммуноглобулина G |